High Capacity Pharmaceutical Single Punch Pill Press Effervescent Tablet Press Machine

Name: High Capacity Pharmaceutical Single Punch Pill Press Effervescent Tablet Press Machine
Brand: Hangzhou Shengde Machinery Co., Ltd.
SKU: 931326455

Zhejiang, ChinaHangzhou Shengde Machinery Co., Ltd.

US$9,009.00

1 Piece

Product profile

Customization

Available

Application

Cosmetic Industry, Food Industry, Food Safety, Pharmaceutical Industry

Automation Grade

Automatic

Model NO.

SED-150HY-B

Capacity

2400 PCS/Hour

Certification

CE, GMP, ISO

Material

Stainless Steel

Safety Features

Overload Protection

Warranty

1 Year

Model

Sed-150hy-B

Maximum Tablet Pressure (kN)

150

Maximum Tablet Diameter (mm)

Finished Dosage Form

Tablet

Precision

High Precision

Voltage

220V

Condition

New

Type

Tablet Machine

Transport Package

Wooden Box

Specification

2120*980*960mm

Trademark

SED-pharma

Origin

Hangzhou, Zhejiang

Production Capacity

500 Set

Company profile

Hangzhou Shengde Machinery Co., Ltd.

Zhejiang, China

CertifiedBusiness Type: Trading Company CertifiedR&D Capacity: OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 8 years CertifiedNearest Port: Ningbo PortAverage Response Time: ≤5.95h

AI-Powered supplier vetting

SummaryHangzhou Shengde Machinery Co., Ltd. is a China-based trading company established in 2018 and organized as a limited company. It offers pharmaceutical and packaging equipment, including capsule, tablet, counting, freeze-drying, filling, and blister-packing machines. The available information indicates weak documented service-management controls, no overseas service infrastructure, and limited innovation resources: it is not identified as a professional technical supplier, has no recent new-product development, does not provide ODM or 3D software design services, and reports only two years of R&D engineer experience. However, it supports multiple forms of customization, provides OEM services for well-known brands, and reports more than ten production lines and 6–10 quality-control staff. An audit record by CTI is valid from April 8, 2026 to April 7, 2027, but the stated evaluation result is 0, with no interpretation provided.

After-Sales capabilityThe supplier has no written procedures or records for service-capability assessment, approved-supplier management, corrective and preventive actions, or effective complaint handling. It also reports no overseas warehouse, overseas showroom, overseas agent, or overseas branch, indicating a documented weakness in service governance and overseas support infrastructure.

R&D capabilityThe supplier is not identified as a professional technical supplier, does not provide 3D software design services, has not introduced a new product in the past year, does not offer ODM services, and has no available SDK. Its R&D engineering experience is reported as 2 years. These explicit limitations indicate weak demonstrated innovation capability.

Production capacityThe supplier offers seven categories of machinery and reports more than ten production lines, 6–10 quality-control staff, and a factory location in Guizhou Province. These data support an established production setup, although the employee counts differ between records and no direct capacity verification is provided.

Customization capabilityThe supplier explicitly supports customization from samples, customization from designs, full customization, minor customization, and flexible customization. Although it does not offer ODM and has no recent new-product development, the stated customization options demonstrate broad customer-specific adaptation capability.

Client casesThe supplier explicitly states that it provides OEM services for well-known brands, which is evidence of at least one type of brand-related customer engagement. No customer names, project details, order history, or independently verifiable case studies are provided, so the breadth and quality of its customer cases cannot be assessed.